Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Adaptive Athlete Announces 300 Skydives in 24 Hours

“300 Imperfect Jumps” Raises Funds for Parkinson’s Disease Research

MINNEAPOLIS, MN — On Wednesday, June 15, 2016, Kevin Burkart, will host “300 Imperfect Jumps,” and will attempt to jump out of a plane with one arm 300 times in one day, in honor of his father who is living with Parkinson’s disease (PD).  Burkart will attempt to set an adaptive athlete world record for skydiving. The event will be held at Skydive Twin Cities in Baldwin, Wisconsin.

“I’m doing this for my dad, Gary, who has been living with Parkinson’s since 1999. I decided to combine my two passions—skydiving and raising awareness of Parkinson’s—to make a difference in my dad’s life and the one million Americans living with PD,” said Kevin Burkart. “As hard as it is to skydive with one arm, it’s even harder to face this disease on a daily basis.”

In 2008, Burkart completed “100 Perfect Jumps” in one day and raised $48,000 for Parkinson’s disease research. In 2010, he upped the ante and completed 150 skydives and raised $78,000. In 2013, after a spinal cord injury left one arm paralyzed, Burkart returned to the skies and completed 151 “Imperfect Jumps for Parkinson’s Disease” and raised an additional $135,000 for a grand total of nearly $250,000. 

“Everyone at the National Parkinson Foundation is rooting for Kevin and his ambitious goal of 300 skydives in one day with one arm,” said Paul Blom, NPF’s Interim CEO. “Kevin is an inspiration to so many and his message is one of triumph in the face of adversity.”

This year, Burkart’s goal is to raise $300,000 for the National Parkinson Foundation’s (NPF) Team Hope™ community fundraising program. Proceeds from the event will support NPF’s mission to make life better for people with Parkinson’s through expert care and research and will support local programs at the NPF Minnesota Chapter.

The public is invited to join the fight against Parkinson’s with Kevin on June 15, 2016 or join him virtually by sponsoring a jump online. Donations can be made online at: Follow “300 Imperfect Jumps” on Facebook at and on Twitter at @parkinsonmn.

Wednesday, June 8, 2016
In Memory of Robert Traurig
Wednesday, July 18, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member Robert (Bob) Traurig. From 2004 to 2015, he was a member of the Foundation’s board of directors. Bob is survived by his wife Jacqueline, his daughters Madeline Sackel and Wendy Traurig.

New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.


mail icon

Subscribe to get the latest news on treatments, research and other updates.